Biofrontera Inc. (BFRI)
Biofrontera Inc. (BFRI) is seeing increased social media attention with a 176.82% rise in engagements over the past month and a 134.01% increase in mentions over the past week, driven by anticipation of Phase [--] & [--] clinical trial readouts in Q1 [----].
About Biofrontera Inc.
Biofrontera Inc. is a biopharmaceutical company focused on developing and commercializing innovative medical devices and treatments for skin diseases.
Biofrontera Inc. uses the ticker $BFRI for trading. Listed in the Stocks category.
Insights
- Biofrontera Inc. (BFRI) social dominance hit [------] which is 262% higher than it's daily average.
- Biofrontera Inc. (BFRI) creators is up 65.43% from the previous week.
- Biofrontera Inc. (BFRI) engagements is up 176.82% from the previous month.
- Biofrontera Inc. (BFRI) mentions is up 134.01% from the previous week.
- Biofrontera Inc. (BFRI) posts created is up 141.67% from the previous week.
Price: $0.779
Price 24-Hour Time-Series Raw Data
The stock price is experiencing an upward trend, likely driven by positive clinical trial results and anticipated FDA approval, which has generated substantial investor optimism and increased trading volume.
24-Hour: -0.43% 7-Day: -3.22% 30-Day: -6.47%
1-Year High: $1.20 on 2025-11-06
1-Year Low: $0.57 on 2025-12-31
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
Biofrontera Inc. (BFRI) is currently AltRank #749 based on combined combined social and market metrics
Daily Average: [-----]
[--] Week: [---] +282
1-Year High: [-----] on 2026-02-04
1-Year Low: [---] on 2026-02-10
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
1-Year High: [--] on 2026-02-09
1-Year Low: [--] on 2026-02-03
Engagements: [------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [-----]
[--] Week: [-------] +43%
[--] Month: [-------] +177%
[--] Months: [-------] -14%
[--] Year: [---------] -24%
1-Year High: [------] on 2025-05-15
1-Year Low: [--] on 2025-10-27
Engagements by network (24h): X: [------] Reddit: [--] News: [--] YouTube: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +134%
1-Year High: [---] on 2025-06-30
1-Year Low: [--] on 2025-10-27
Mentions by network (24h): X: [--] Reddit: [--] News: [--] YouTube: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Biofrontera Inc. (BFRI) in the last [--] hours which is down 59% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] +65%
1-Year High: [---] on 2025-06-30
1-Year Low: [--] on 2025-10-27
The most influential creators that mention Biofrontera Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | [--] | [------] | [--] | [------] |
| @Rocket_Labs22 | [--] | [---] | [--] | [---] |
| @LucyTrader98 | [--] | [---] | [--] | [---] |
| @ElSheikh_Stock | [--] | [-----] | [--] | [--] |
| @Pro_Trader0000 | [--] | [--] | [--] | [--] |
| @SeanValenc89161 | [--] | [---] | [--] | [--] |
| @SandraG62844642 | [--] | [---] | [--] | [--] |
| @ArundhatiRashmi | [--] | [--] | [--] | [--] |
| @MiriamF24887120 | [--] | [--] | [--] | [--] |
| @PaulAlesinis | [--] | [--] | [--] | [--] |
Sentiment: 80%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 80%
Daily Average: 84%
[--] Week: 67% -22%
[--] Month: 57% -3%
[--] Months: 57% +17%
[--] Year: 57% -43%
1-Year High: 100% on 2025-02-17
1-Year Low: 14% on 2025-09-19
Most Supportive Themes:
- Phase [--] & [--] Readouts in Q1 2026: (60%) Biofrontera Inc. is anticipated to have Phase [--] and Phase [--] clinical trial readouts in the first quarter of 2026, indicating potential advancements in their drug development pipeline.
- Biopharma Weekly Recap: (30%) The company is mentioned within broader biopharma market discussions, highlighting trends like M&A chatter and AI drug discovery.
Most Critical Themes:
Social Dominance: 0.00528%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00528%
Daily Average: 0.00461%
[--] Week: 0.013% -0.013%
[--] Month: 0.017% +0.015%
[--] Months: 0.017% +0.012%
[--] Year: 0.017% +0.012%
1-Year High: 0.033% on 2025-06-30
1-Year Low: 0.0002% on 2025-10-27
Market Dominance: 0.000010160069777622608%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.000010160069777622608%
Daily Average: 0%
1-Year High: 0.00044% on 2026-02-06
1-Year Low: 0.00001% on 2026-02-16
Market Cap: $8,969,209
Market Cap 24-Hour Time-Series Raw Data
Current Value: $8,969,209
Daily Average: $10,170,417
[--] Week: $8,969,209 -4%
[--] Month: $9,070,549 -6.50%
1-Year High: $11,648,323 on 2026-01-22
1-Year Low: $8,968,044 on 2026-02-11
Top Biofrontera Inc. Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $BIVI Phase [--] $MDNAF Phase 2b $DBVT Phase [--] $GOSS Phase [--] $MLTX Phase [--] $BFRI Phase [--] $BCDA Phase [--] $KPTI Phase [--] $IOVA Phase [--] $XENE Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $ALZN Phase [--] $HELP Phase [--] $PVLA Phase [--] $INSM"
X Link @BiopharmIQ 2026-02-15T19:38Z 28.9K followers, [----] engagements
"🧬 Biopharma Weekly Recap 📝 This week in biotech: $NKTR AtD data and financing ignite upside debate GLP-1 pill surge boosts $NVO/$LLY M&A chatter builds and dense Q1 readouts drive volatility. See interesting posts/ppl to check out 👇 @AppleHelix 1/ There is some confusion with the reporting on $MRNA Refuse to File. @seedy19tron The Weekly 🌱 New: $anl $tern $cmps Increased: $abvx $nktr Unchanged: $nxtc $ovid $slno $cntx $pasg $dawn $lqda $rytm Decreased: Closed: $crvs (s) $apge (s) $asnd $ptn $cogt @Andre_AGTC My watch list near term catalysts @ResearchPulse1 Can UBT251 from NVO be a"
X Link @BiopharmIQ 2026-02-14T16:03Z 28.9K followers, 11.5K engagements
"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $MDNAF Phase 2b $GOSS Phase [--] $BFRI Phase [--] $MLTX Phase [--] $BFRI Phase [--] $BCDA Phase [--] $KPTI Phase [--] $IOVA Phase [--] $XENE Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $ZBIO Phase [--] $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $NKTR Phase 2b $ALZN Phase [--] $HELP Phase [--] $PVLA"
X Link @BiopharmIQ 2026-02-08T18:59Z 28.9K followers, 19.9K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing